You can get access to information on Huons and its development of new products

• 51
  Huons Announces Poster Presentation on Preclinical Results of 'Fibrostenotic Crohn’s Disease Treatment' at the UEG Week 2026 PR · 2026.10.20
• 50
  Huons Enters Exclusive Distribution Agreement with Substipharm Biologics for Japanese Encephalitis Vaccine 'Imojev®' PR · 2026.10.01
• 49
  Huons Selected for 3 National R&D Projects for Joint New Drug Development PR · 2026.09.15
• 48
  PanGen Biotech Reports Q2 Revenue of KRW 3.96 Billion, Up 13.5% YoY PR · 2026.08.13
• 47
  Huons Reports 2026 Q2 Separate Revenue of KRW 117.6 Billion and Operating Profit of KRW 7.3 Billion PR · 2026.08.11
• 46
  Huons N Completes Expansion of Chuncheon Plant, Boosting Competitiveness in Health Functional Food Production PR · 2026.07.09
• 45
  Huons Advances Phase 2 Clinical Trial of Peptide-Based Dry Eye Disease Drug 'HUC1-394' with First Patient Enrollment 홍보팀 · 2026.07.03
• 44
  Huons N Completes Merger with Health Functional Food Manufacturing Subsidiary 'BioRosette' PR · 2026.07.02
• 43
  Huons Completes Merger with Huons Life Sciences PR · 2026.06.26
• 42
  Huons Selected for National Drug Development Program to Advance Fibrostenotic Crohn’s Disease Treatment huons · 2026.06.23

All Title Content Writer